Terms: = Gastric cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
60 results:
1. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an vegfr-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
[TBL] [Abstract] [Full Text] [Related]
2. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Management of gastric cancer Treatment Regimens.
Boilève J; Touchefeu Y; Matysiak-Budnik T
Curr Top Microbiol Immunol; 2023; 444():279-304. PubMed ID: 38231223
[TBL] [Abstract] [Full Text] [Related]
4. gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.
Wang B; Zhu Y; Wang S; Li Z; Wang L; Rao W; Cheng N; Chen R; Ying J; Xue L
Gastric Cancer; 2024 Jan; 27(1):86-101. PubMed ID: 38019350
[TBL] [Abstract] [Full Text] [Related]
5. Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.
Hyung S; Ko J; Heo YJ; Blum SM; Kim ST; Park SH; Park JO; Kang WK; Lim HY; Klempner SJ; Lee J
Sci Adv; 2023 Nov; 9(47):eadk1098. PubMed ID: 38000030
[TBL] [Abstract] [Full Text] [Related]
6. Genomic and Transcriptomic Characterization of gastric cancer with Bone Metastasis.
Oh S; Nam SK; Lee KW; Lee HS; Park Y; Kwak Y; Lee KS; Kim JW; Kim JW; Kang M; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH
Cancer Res Treat; 2024 Jan; 56(1):219-237. PubMed ID: 37591783
[TBL] [Abstract] [Full Text] [Related]
7. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
Huang Z; Yang H; Lao J; Deng W
PLoS One; 2023; 18(7):e0287303. PubMed ID: 37467193
[TBL] [Abstract] [Full Text] [Related]
8. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal Breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-d]pyrimidin/pyrazolo[3,4-d]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancer.
Wu X; Liu Z; Gan C; Wei W; Zhang Q; Liu H; Que H; Su X; Yue L; He H; Ouyang L; Ye T
Bioorg Chem; 2022 Oct; 127():105965. PubMed ID: 35759882
[TBL] [Abstract] [Full Text] [Related]
10. The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data.
Iwasa S; Bando H; Piao Y; Yoshizawa K; Yamaguchi K
Future Oncol; 2022 Jul; 18(21):2709-2721. PubMed ID: 35703103
[TBL] [Abstract] [Full Text] [Related]
11. Abnormal phenotype of Nrf2 is associated with poor prognosis through hypoxic/VEGF-A-Rap1b/vegfr2 pathway in gastric cancer.
Yang Y; Wang X; Zhang J; Gu H; Zhang S; Sun H; Liu J; Fan R
Aging (Albany NY); 2022 Apr; 14(7):3293-3312. PubMed ID: 35417854
[TBL] [Abstract] [Full Text] [Related]
12. [Profilin 2 is highly expressed in gastric cancer and promotes tumor cell proliferation and migration].
Hu S; Shi L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):215-222. PubMed ID: 35365445
[TBL] [Abstract] [Full Text] [Related]
13. Dual blockade of MET and vegfr2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer.
Kasai S; Kuwayama N; Motoo Y; Kawashima A; Matsumoto K; Yano S; Matsushima K; Yasumoto K
Biochem Biophys Res Commun; 2022 Apr; 600():80-86. PubMed ID: 35196631
[TBL] [Abstract] [Full Text] [Related]
14. Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-vegfr2 antibody on gastric cancer in vivo.
Mashima T; Wakatsuki T; Kawata N; Jang MK; Nagamori A; Yoshida H; Nakamura K; Migita T; Seimiya H; Yamaguchi K
Sci Rep; 2021 Jul; 11(1):15125. PubMed ID: 34302038
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the vegfr-2 signaling pathway in gastric cancer.
Teng F; Zhang JX; Chen Y; Shen XD; Su C; Guo YJ; Wang PH; Shi CC; Lei M; Cao YO; Liu SQ
Mol Oncol; 2021 Apr; 15(4):1234-1255. PubMed ID: 33512745
[TBL] [Abstract] [Full Text] [Related]
16. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/kdr/MMP9 and P53/BCL2L1/CASP3/7 pathways.
Liang R; Chen W; Chen XY; Fan HN; Zhang J; Zhu JS
Pathol Res Pract; 2021 Feb; 218():153318. PubMed ID: 33370709
[TBL] [Abstract] [Full Text] [Related]
17. High
Dazhi W; Zheng J; Chunling R
Future Med Chem; 2020 Dec; 12(24):2209-2224. PubMed ID: 33191789
[No Abstract] [Full Text] [Related]
18. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract] [Full Text] [Related]
19. The regulatory mechanism and biological significance of the Snail-miR590-vegfr-NRP1 axis in the angiogenesis, growth and metastasis of gastric cancer.
Mei B; Chen J; Yang N; Peng Y
Cell Death Dis; 2020 Apr; 11(4):241. PubMed ID: 32303680
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
Zhao H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
[TBL] [Abstract] [Full Text] [Related]
[Next]
